Skip to main content
. Author manuscript; available in PMC: 2020 Jul 27.
Published in final edited form as: J Urol. 2019 Oct 9;203(4):699–705. doi: 10.1097/JU.0000000000000587

Figure 5.

Figure 5.

Cancer detection rate (LEFT), clinically-significant prostate cancer detection rate (MIDDLE), and GG≥2 detection rate (RIGHT) stratified by PSAD. Template mapping biopsy detected more cancers overall and more clinically-significant cancers in patients with PSAD<0.15.